PRIMARY STUDY

Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases

Key Findings:  Recent discoveries in cannabinoid-based pharmacology suggests a successful route of various types of cannabinoids to be employed in the treatment of neurodegeneration associated with Parkinson's, Alzheimer's, and Huntington's disease.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Spain

Year of Pub:  2021


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified

Receptors Studied:  CB1, CB2, GPCR 3, GPCR 6, GPCR 18, GPCR 55, PPARs